Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT).

Full DD Report for ICPT

You must become a subscriber to view this report.

Recent News from (NASDAQ: ICPT)

Premarket analyst action - healthcare
Zealand Pharma A/S (NASDAQ: ZEAL ) resumed with Overweight rating at Morgan Stanley following its $205M deal with Royalty Pharma. More news on: Zealand Pharma, Intercept Pharmaceuticals, Vital Therapies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 12 2018 08:34
Today's Research Reports on Trending Tickers: Amicus Therapeutics and Intercept Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / September 10, 2018 / Wall Street plunged on Friday after the Trump administration announced tariffs on another $267 billion worth of Chinese goods, pressuring the S&P 500 and Nasdaq to close down for the fourth consecutive session. The Dow Jones Industrial Av...
Date: September, 10 2018 08:00
Breaking Down The NASH Fibrosis Market - Intercept, Genfit Primed For Potential Market Dominance
Over the past year, interest has heated up in the biotech industry about NASH, with analysts estimating market size in 2025 anywhere between $20-35 billion. Positive Phase 2 data readouts for Madrigal (NASDAQ: MDGL ) and Galmed (NASDAQ: GLMD ) caused both stocks to more than double overnight...
Source: SeekingAlpha
Date: September, 10 2018 08:00
Small Caps Are Rising, Biotechs Can't Be Far Behind
Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...
Source: SeekingAlpha
Date: September, 05 2018 13:31


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ICPT.

About Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)

Logo for Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)

Not available


Contact Information



    Current Share Structure

    • Market Cap: $2,111,647,388 - 05/16/2018
    • Authorized: 45,000,000 - 05/01/2018
    • Issue and Outstanding: 29,583,180 - 05/01/2018


    Daily Technical Chart for (NASDAQ: ICPT)

    Daily Technical Chart for (NASDAQ: ICPT)

    Stay tuned for daily updates and more on (NASDAQ: ICPT)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: ICPT)

    Do your DD and if you choose, be ready to go!


    The Research: All source information contained in this email is from the public sources mentioned below.



    Thank you

    DD Report



    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ICPT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ICPT and does not buy, sell, or trade any shares of ICPT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: